Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques.
Rhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef¯ simian immunodeficiency virus (Rev-Ind Nef¯SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuat...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3787041?pdf=render |
_version_ | 1819181958035406848 |
---|---|
author | Siddappa N Byrareddy Mila Ayash-Rashkovsky Victor G Kramer Sandra J Lee Mick Correll Francis J Novembre Francois Villinger Welkin E Johnson Agneta von Gegerfelt Barbara K Felber Ruth M Ruprecht |
author_facet | Siddappa N Byrareddy Mila Ayash-Rashkovsky Victor G Kramer Sandra J Lee Mick Correll Francis J Novembre Francois Villinger Welkin E Johnson Agneta von Gegerfelt Barbara K Felber Ruth M Ruprecht |
author_sort | Siddappa N Byrareddy |
collection | DOAJ |
description | Rhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef¯ simian immunodeficiency virus (Rev-Ind Nef¯SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuated virus to protect RMs against pathogenic, heterologous SIVsmE660 challenges.Three groups of four RM were inoculated with Rev-Ind Nef¯SIV and compared. Group 1 was inoculated 8 years prior and again 15 months before low dose intrarectal challenges with SIVsmE660. Group 2 animals were inoculated with Rev-Ind Nef¯SIV at 15 months and Group 3 at 2 weeks prior to the SIVsmE660 challenges, respectively. Group 4 served as unvaccinated controls. All RMs underwent repeated weekly low-dose intrarectal challenges with SIVsmE660. Surprisingly, all RMs with acute live-attenuated virus infection (Group 3) became superinfected with the challenge virus, in contrast to the two other vaccine groups (Groups 1 and 2) (P=0.006 for each) and controls (Group 4) (P=0.022). Gene expression analysis showed significant upregulation of innate immune response-related chemokines and their receptors, most notably CCR5 in Group 3 animals during acute infection with Rev-Ind Nef¯SIV.We conclude that although Rev-Ind Nef¯SIV remained apathogenic, acute replication of the vaccine strain was not protective but associated with increased acquisition of heterologous mucosal SIVsmE660 challenges. |
first_indexed | 2024-12-22T22:38:30Z |
format | Article |
id | doaj.art-a11177e724aa46129c4cd521501ea077 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-22T22:38:30Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-a11177e724aa46129c4cd521501ea0772022-12-21T18:10:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7555610.1371/journal.pone.0075556Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques.Siddappa N ByrareddyMila Ayash-RashkovskyVictor G KramerSandra J LeeMick CorrellFrancis J NovembreFrancois VillingerWelkin E JohnsonAgneta von GegerfeltBarbara K FelberRuth M RuprechtRhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef¯ simian immunodeficiency virus (Rev-Ind Nef¯SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuated virus to protect RMs against pathogenic, heterologous SIVsmE660 challenges.Three groups of four RM were inoculated with Rev-Ind Nef¯SIV and compared. Group 1 was inoculated 8 years prior and again 15 months before low dose intrarectal challenges with SIVsmE660. Group 2 animals were inoculated with Rev-Ind Nef¯SIV at 15 months and Group 3 at 2 weeks prior to the SIVsmE660 challenges, respectively. Group 4 served as unvaccinated controls. All RMs underwent repeated weekly low-dose intrarectal challenges with SIVsmE660. Surprisingly, all RMs with acute live-attenuated virus infection (Group 3) became superinfected with the challenge virus, in contrast to the two other vaccine groups (Groups 1 and 2) (P=0.006 for each) and controls (Group 4) (P=0.022). Gene expression analysis showed significant upregulation of innate immune response-related chemokines and their receptors, most notably CCR5 in Group 3 animals during acute infection with Rev-Ind Nef¯SIV.We conclude that although Rev-Ind Nef¯SIV remained apathogenic, acute replication of the vaccine strain was not protective but associated with increased acquisition of heterologous mucosal SIVsmE660 challenges.http://europepmc.org/articles/PMC3787041?pdf=render |
spellingShingle | Siddappa N Byrareddy Mila Ayash-Rashkovsky Victor G Kramer Sandra J Lee Mick Correll Francis J Novembre Francois Villinger Welkin E Johnson Agneta von Gegerfelt Barbara K Felber Ruth M Ruprecht Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. PLoS ONE |
title | Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. |
title_full | Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. |
title_fullStr | Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. |
title_full_unstemmed | Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. |
title_short | Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. |
title_sort | live attenuated rev independent nef¯siv enhances acquisition of heterologous sivsme660 in acutely vaccinated rhesus macaques |
url | http://europepmc.org/articles/PMC3787041?pdf=render |
work_keys_str_mv | AT siddappanbyrareddy liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT milaayashrashkovsky liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT victorgkramer liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT sandrajlee liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT mickcorrell liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT francisjnovembre liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT francoisvillinger liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT welkinejohnson liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT agnetavongegerfelt liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT barbarakfelber liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques AT ruthmruprecht liveattenuatedrevindependentnefsivenhancesacquisitionofheterologoussivsme660inacutelyvaccinatedrhesusmacaques |